TAGRISSO Trademark

Trademark Overview

On Friday, November 20, 2015, a trademark application was filed for TAGRISSO with the United States Patent and Trademark Office. The USPTO has given the TAGRISSO trademark a serial number of 86827065. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, June 7, 2023. This trademark is owned by AstraZeneca AB. The TAGRISSO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology
tagrisso

General Information

Serial Number86827065
Word MarkTAGRISSO
Filing DateFriday, November 20, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, June 7, 2023
Registration Number5117285
Registration DateTuesday, January 10, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 21, 2016

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Amendment to a Registration/Renewal CertificateThe drawing is amended to appear as follows: PUBLISH NEW CUT; and in the statement, line 9, is deleted, and The mark consists of a set of lungs appearing to the left of the wording "Tagrisso", is inserted.
Description of MarkThe mark consists of a set of lungs appearing to the left of the wording "Tagrisso".
Goods and ServicesPharmaceutical preparations and substances for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 25, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Tuesday, November 24, 2015NEW APPLICATION ENTERED
Wednesday, November 25, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 26, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, December 10, 2015ASSIGNED TO EXAMINER
Friday, December 11, 2015NON-FINAL ACTION WRITTEN
Friday, December 11, 2015NON-FINAL ACTION E-MAILED
Friday, December 11, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 25, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 6, 2016ASSIGNED TO LIE
Tuesday, May 10, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 10, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 16, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 1, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 21, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 21, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 16, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 2, 2016TEAS DELETE 1(B) BASIS RECEIVED
Monday, November 28, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 2, 2016NOTICE OF ALLOWANCE CANCELLED
Thursday, December 8, 20161(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, January 10, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 10, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, March 16, 2022TEAS SECTION 7 REQUEST RECEIVED
Tuesday, August 16, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, August 19, 2022POST REGISTRATION ACTION MAILED - SEC. 7
Monday, October 24, 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Tuesday, October 25, 2022AMENDMENT UNDER SECTION 7 - PROCESSED
Tuesday, November 29, 2022NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Thursday, December 1, 2022TEAS SECTION 8 & 15 RECEIVED
Wednesday, June 7, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 7, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 7, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, January 10, 2026COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

tagrisso oncology substances preparations pharmaceutical